Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,168
Closed -$88K 2547
2026
Q1
$88K Buy
1,168
+332
+40% +$25K ﹤0.01% 1331
2025
Q4
$62K Sell
836
-170
-17% -$12.4K ﹤0.01% 1344
2025
Q3
$68K Sell
1,006
-93
-8% -$6.17K ﹤0.01% 1119
2025
Q2
$72K Sell
1,099
-134
-11% -$8.03K ﹤0.01% 842
2025
Q1
$76K Sell
1,233
-1,805
-59% -$120K ﹤0.01% 647
2024
Q4
$219K Sell
3,038
-102,113
-97% -$7.98M ﹤0.01% 553
2024
Q3
$8.57M Buy
105,151
+1,357
+1% +$109K 0.15% 161
2024
Q2
$7.71M Sell
103,794
-6,013
-5% -$451K 0.15% 167
2024
Q1
$8.56M Sell
109,807
-5,524
-5% -$411K 0.17% 158
2023
Q4
$8.24M Sell
115,331
-5,571
-5% -$388K 0.18% 164
2023
Q3
$8.39M Buy
120,902
+1,307
+1% +$98.8K 0.21% 143
2023
Q2
$9.68M Buy
+119,595
New +$9.77M 0.24% 124
2022
Q2
Sell
-200
Closed -$15K 1072
2022
Q1
$15K Buy
+200
New +$14.4K ﹤0.01% 725
2020
Q3
Sell
-2,646
Closed -$151K 593
2020
Q2
$151K Buy
2,646
+1,334
+102% +$65.5K 0.01% 387
2020
Q1
$46K Buy
+1,312
New +$62.5K ﹤0.01% 434

Other funds holding HOLX

Hantz Financial Services's HOLX Position: Q2 2026 in Review

Hantz Financial Services sold out of Hologic (HOLX) in Q2 2026, closing a stake of 1,168 shares — an estimated $88K sold.

Hantz Financial Services first reported a position in HOLX in Q1 2020 and held it in 15 quarters. The position peaked at $9.68M in Q2 2023. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Hantz Financial Services reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Hantz Financial Services sold 1,168 Hologic shares in Q2 2026, an estimated $88K.
  • Hantz Financial Services first reported a position in Hologic in Q1 2020 and held it in 15 quarters.
  • Hantz Financial Services's Hologic position peaked at $9.68M in Q2 2023.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Hantz Financial Services's 13F filing for Q2 2026, filed 13 Aug 2026.